Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerry-Anne Rye

Showing results (1-10 of 270) with videos related to

Pageof 27
Sort By:
Journal of Lipid Research|June 21, 2013
High density lipoprotein structure, function, and metabolism: a new Thematic SeriesKerry-Anne Rye
Clinical and Experimental Nephrology|September 21, 2013
Biomarkers associated with high-density lipoproteins in atherosclerotic kidney diseaseKerry-Anne Rye
Trends in Pharmacological Sciences|November 18, 2011
Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: Where are we now?Philip Barter, Kerry-Anne Rye
Nature Clinical Practice. Cardiovascular Medicine|May 27, 2006
Are we lowering LDL cholesterol sufficiently?Philip Barter, Kerry-Anne Rye
Clinical Science (London, England : 1979)|December 17, 2008
High-density lipoproteins, inflammation and oxidative stressFatiha Tabet, Kerry-Anne Rye
Journal of Lipid Research|December 4, 2018
A Letter from the Editors-in-ChiefKerry-Anne Rye, Nick Davidson
Nature Reviews. Cardiology|April 8, 2016
Coronary artery disease: Scavenger receptor class B1--a target to reduce CHD risk?Philip J Barter, Kerry-Anne Rye
Circulation|September 20, 2006
Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statinsPhilip J Barter, Kerry-Anne Rye
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2003
Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-IKerry-Anne Rye, Philip J Barter
Journal of Lipid Research|May 3, 2012
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular riskPhilip J Barter, Kerry-Anne Rye
Pageof 27

Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
Journal of Lipid Research|June 21, 2013
High density lipoprotein structure, function, and metabolism: a new Thematic SeriesKerry-Anne Rye
Clinical and Experimental Nephrology|September 21, 2013
Biomarkers associated with high-density lipoproteins in atherosclerotic kidney diseaseKerry-Anne Rye
Trends in Pharmacological Sciences|November 18, 2011
Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: Where are we now?Philip Barter, Kerry-Anne Rye
Nature Clinical Practice. Cardiovascular Medicine|May 27, 2006
Are we lowering LDL cholesterol sufficiently?Philip Barter, Kerry-Anne Rye
Clinical Science (London, England : 1979)|December 17, 2008
High-density lipoproteins, inflammation and oxidative stressFatiha Tabet, Kerry-Anne Rye
Journal of Lipid Research|December 4, 2018
A Letter from the Editors-in-ChiefKerry-Anne Rye, Nick Davidson
Nature Reviews. Cardiology|April 8, 2016
Coronary artery disease: Scavenger receptor class B1--a target to reduce CHD risk?Philip J Barter, Kerry-Anne Rye
Circulation|September 20, 2006
Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statinsPhilip J Barter, Kerry-Anne Rye
Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 2003
Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-IKerry-Anne Rye, Philip J Barter
Journal of Lipid Research|May 3, 2012
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular riskPhilip J Barter, Kerry-Anne Rye
Pageof 27